446 related articles for article (PubMed ID: 28530125)
21. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
[TBL] [Abstract][Full Text] [Related]
22. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
24. TSPO Modulates IL-4-Induced Microglia/Macrophage M2 Polarization via PPAR-γ Pathway.
Zhou D; Ji L; Chen Y
J Mol Neurosci; 2020 Apr; 70(4):542-549. PubMed ID: 31879837
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
[TBL] [Abstract][Full Text] [Related]
26. From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury.
Delage C; Vignal N; Guerin C; Taib T; Barboteau C; Mamma C; Khacef K; Margaill I; Sarda-Mantel L; Rizzo-Padoin N; Hontonnou F; Marchand-Leroux C; Lerouet D; Hosten B; Besson V
Sci Rep; 2021 Dec; 11(1):24009. PubMed ID: 34907268
[TBL] [Abstract][Full Text] [Related]
27. Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands.
Owen DR; Matthews PM
Int Rev Neurobiol; 2011; 101():19-39. PubMed ID: 22050847
[TBL] [Abstract][Full Text] [Related]
28. Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling.
Horiguchi Y; Ohta N; Yamamoto S; Koide M; Fujino Y
Int Immunopharmacol; 2019 Jan; 66():373-382. PubMed ID: 30530051
[TBL] [Abstract][Full Text] [Related]
29. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
[TBL] [Abstract][Full Text] [Related]
30. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
Notter T; Coughlin JM; Gschwind T; Weber-Stadlbauer U; Wang Y; Kassiou M; Vernon AC; Benke D; Pomper MG; Sawa A; Meyer U
Mol Psychiatry; 2018 Feb; 23(2):323-334. PubMed ID: 28093569
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation.
Monga S; Nagler R; Amara R; Weizman A; Gavish M
Cells; 2019 May; 8(5):. PubMed ID: 31121852
[TBL] [Abstract][Full Text] [Related]
32. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; Reynolds R; Matthews PM; Parker CA
J Nucl Med; 2011 Jan; 52(1):24-32. PubMed ID: 21149489
[TBL] [Abstract][Full Text] [Related]
33. Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration.
Scholz R; Caramoy A; Bhuckory MB; Rashid K; Chen M; Xu H; Grimm C; Langmann T
J Neuroinflammation; 2015 Nov; 12():201. PubMed ID: 26527153
[TBL] [Abstract][Full Text] [Related]
34. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation.
Biechele G; Blume T; Deussing M; Zott B; Shi Y; Xiang X; Franzmeier N; Kleinberger G; Peters F; Ochs K; Focke C; Sacher C; Wind K; Schmidt C; Lindner S; Gildehaus FJ; Eckenweber F; Beyer L; von Ungern-Sternberg B; Bartenstein P; Baumann K; Dorostkar MM; Rominger A; Cumming P; Willem M; Adelsberger H; Herms J; Brendel M
Theranostics; 2021; 11(18):8964-8976. PubMed ID: 34522221
[TBL] [Abstract][Full Text] [Related]
35. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [
Brody AL; Hubert R; Enoki R; Garcia LY; Mamoun MS; Okita K; London ED; Nurmi EL; Seaman LC; Mandelkern MA
Neuropsychopharmacology; 2017 Jul; 42(8):1630-1639. PubMed ID: 28262740
[TBL] [Abstract][Full Text] [Related]
36. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
[TBL] [Abstract][Full Text] [Related]
37. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.
Hannestad J; DellaGioia N; Gallezot JD; Lim K; Nabulsi N; Esterlis I; Pittman B; Lee JY; O'Connor KC; Pelletier D; Carson RE
Brain Behav Immun; 2013 Oct; 33():131-8. PubMed ID: 23850810
[TBL] [Abstract][Full Text] [Related]
38. TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.
Loth MK; Choi J; McGlothan JL; Pletnikov MV; Pomper MG; Guilarte TR
Neurobiol Dis; 2016 Jan; 85():174-186. PubMed ID: 26545928
[TBL] [Abstract][Full Text] [Related]
39. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [
Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; ; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Mol Psychiatry; 2017 Jun; 22(6):850-856. PubMed ID: 28194003
[TBL] [Abstract][Full Text] [Related]
40. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
